1. A unique biological in-vivo model to evaluate follicular development during in-vitro maturation treatment 
S.E. Elizur, W.Y. Son, H. Clarke, D. Morris, Y. Gidoni, E. Demirtas, S.L. Tan 
Reproductive BioMedicine Online 
Volume 22, Issue 3, Pages (March 2011)
DOI: /j.rbmo
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1
Serum oestradiol concentrations 7–9days after 10,000IU human chorionic gonadotrophin (HCG) injection in 12 women with regular cycles undergoing HCG-primed in-vitro maturation treatment without hormonal luteal support.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

3. Figure 2
Serum progesterone concentrations 7–9days after 10,000IU human chorionic gonadotrophin (HCG) injection in 13 women with regular cycles undergoing HCG-primed in-vitro maturation treatment without hormonal luteal support.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

4. Figure 3
Receiver operating characteristic curve of the dominant follicle diameter predicting the formation of a progesterone-producing corpus luteum (>10nmol/l) in response to LH surge 7–9days after human chorionic gonadotrophin administration.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions